Importance Limited information about the relationship between specific mutations
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer …

Background: Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy,
responsible for 13 000 deaths per year in the United States. Risk prediction based on …

Purpose: To elucidate molecular pathways contributing to metastatic cancer progression
and poor clinical outcome in serous ovarian cancer. Experimental Design: Poor survival …

Importance Cytotoxic CD8 + tumor-infiltrating lymphocytes (TILs) participate in immune control
of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8 + …

Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC)
susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and …

The prevalence and spectrum of germline mutations in BRCA1 and BRCA2 have been reported
in single populations, with the majority of reports focused on White in Europe and North …

Sarcomas are a broad family of mesenchymal malignancies exhibiting remarkable histologic
diversity. We describe the multi-platform molecular landscape of 206 adult soft tissue …

Purpose: To analyze the effect of germline mutations in BRCA1 and BRCA2 on mortality in
patients with ovarian cancer up to 10 years after diagnosis. Experimental Design: We used …

Purpose We assessed the associations between population-based polygenic risk scores (PRS)
for breast (BC) or epithelial ovarian cancer (EOC) with cancer risks for BRCA1 and …

Common variants in 94 loci have been associated with breast cancer including 15 loci with
genome-wide significant associations (P<5 × 10 −8 ) with oestrogen receptor (ER)-negative …